Summary
- Profile Type
- Business Offer
- POD Reference
- BODE20240822001
- Term of Validity
- 22 August 2024 - 22 August 2025
- Company's Country
- Germany
- Type of partnership
- Commercial agreement
- Outsourcing agreement
- Supplier agreement
- Targeted Countries
- France
- Croatia
- Czechia
- Denmark
- Austria
- Bulgaria
- Greece
- Estonia
- Finland
- Belgium
- Serbia
- Montenegro
- Poland
- Ireland
- Italy
- Lithuania
- Romania
- Luxembourg
- Iceland
- Latvia
- Norway
- Netherlands
- Israel
- Portugal
- Slovakia
- Malta
- United Kingdom
- Slovenia
- Japan
- Spain
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The company is specialized in supplying APIs (Active Pharmaceutical Ingredients) and finechemicals especially under GMP (Good Manufacturing Practice) for the pharmaceutical and biotech industry, but also for non GMP applications. Commercial routine production is available for an annual requirement of ca. 100 g to several 100 kg, for special GMP products of orphan disease APIs.
- Full Description
- The German company, located in the South West of German, is specialized in supplying APIs and finechemicals under GMP. The FDA-inspected production facilities in Germany are optimized for g to multi kg quantities, as typically encountered in preclinical research and all clinical phases of API approval. Commercial routine production is available for an annual requirement of ca. 100 g to several 100 kg i.e. for speciality GMP products or orphan disease APIs. The company has broad chemical expertise, including synthetic route and GMP process development for organic small molecules, inorganic salts and complexes as well as medical polymers. The company is certified in the handling or carcinogenic substances and capable of handling legally controlled narcotics. Quality control, analytical development and regulatory support complete the company services. The company is offering commercial agreements, outsourcing agreements, supplier agreements, manufacturing agreements and research and development cooperation agreements for different countries.
- Advantages and Innovations
- high chemical expertise, regulatory expertise, flexibility, projectmanagement, GMP, API, small scale, organic, from preclinics all the way to commercial supply
- Technical Specification or Expertise Sought
-
suitable: GMP, injection grade, pharmaceutical or biotech applications, clinical phase supply, small scale
not suitable: technical grade, bulk chemicals, agrochemicals - Sustainable Development Goals
- Goal 3: Good Health and Well-being
Partner Sought
- Expected Role of a Partner
- The company is looking for innovative pharmaceutical or biotech companies who are looking for a supplier for their new chemcial entity (starting from small scale synthesis, over upscale all the way until GMP production, from pre-clinical phase to clinical phase III and commercial supply). The company is also looking for established or innovative pharmaceutical companies who are looking for a supplier for one of the developed products. GMP or non-GMP development is possible, especially long term with the same understanding of quality (GMP).
- Type and Size of Partner
- SME 11-49
- University
- SME 50 - 249
- R&D Institution
- SME <=10
- Type of partnership
- Commercial agreement
- Outsourcing agreement
- Supplier agreement
Dissemination
- Technology keywords
- 06001015 - Pharmaceutical Products / Drugs
- Market keywords
- 08001023 - Other chemicals and materials (not elsewhere classified)
- 05007007 - Other medical/health related (not elsewhere classified)
- 05007002 - Pharmaceuticals/fine chemicals
- Sector Groups Involved
- Health
- Targeted countries
- France
- Croatia
- Czechia
- Denmark
- Austria
- Bulgaria
- Greece
- Estonia
- Finland
- Belgium
- Serbia
- Montenegro
- Poland
- Ireland
- Italy
- Lithuania
- Romania
- Luxembourg
- Iceland
- Latvia
- Norway
- Netherlands
- Israel
- Portugal
- Slovakia
- Malta
- United Kingdom
- Slovenia
- Japan
- Spain